Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

748189

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Hospital Beds
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many NHS beds were available for mental health patients in each of the last five years.
tabling member constituency	Worsley and Eccles South
tabling member printed	Barbara Keeley
uin	2925
answer	answer is ministerial correction date of answer 10/07/2017 answer text <p>Information is not available in the format requested. NHS England publish quarterly data from all National Health Service organisations that operate beds that are open overnight or day only. This includes the number of mental illness beds. This data is available at the link below:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/07/2017 16:32:28 answering member 4067 label Biography information for Steve Brine
tabling member	1588 label Biography information for Baroness Keeley

748191

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Social Security Benefits
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the Government provides guidance to GP surgeries on whether they should provide supporting letters for disability benefit claims if patients request them.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	2927
answer	answer is ministerial correction date of answer 10/07/2017 answer text <p>NHS England contracts with general practitioners (GPs) as independent providers of medical services for the National Health Service. Under the terms of their contract, GPs are required to provide certain medical reports or complete certain forms, including those related to claiming disability benefits, free of charge to their registered patients.</p><p> </p><p>Outside their contractual requirements, GPs also offer a variety of other services which successive governments have regarded as private matters between the patient and the GP. In such cases, decisions on whether to charge a fee and the level of the fee charged are at the GP’s discretion.</p><p> </p><p>Where GPs intend to charge for services to patients, the British Medical Association (BMA) advises them to forewarn patients, at the earliest opportunity, of the likely level of fees. The BMA also produces guidance on the level of fees that should be charged for commonly provided services.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 2928 question first answered 10/07/2017 14:17:17 answering member 4067 label Biography information for Steve Brine
tabling member	304 label Biography information for Mr Roger Godsiff

748193

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Visual Impairment: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when magnetic implants to improve eyesight will be available on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	2707
answer	answer is ministerial correction date of answer 07/07/2017 answer text <p>It is for local National Health Service commissioners to make decisions on whether to fund new treatments, taking into account National Institute for Health and Care Excellence guidance, available evidence and individual patient’s clinical circumstances.</p><p> </p><p>The future availability of any new or novel treatments would be subject to large scale clinical trials demonstrating the safety and efficacy of the treatment approach and subsequent assessments of its cost effectiveness for routine use.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/07/2017 09:56:28 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

748195

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	HIV Infection
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to continue the reduction in the number of HIV cases in the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	2709
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>Good practice followed at five specialist sexual health clinics (SHCs) that saw a large fall in new diagnoses of HIV among gay and bisexual men will be promoted at other SHCs across the country. The practices include increasing the uptake of testing for all gay and bisexual men by promoting repeat testing among those at higher risk of HIV acquisition and the early commencement of treatment for those who are diagnosed.</p><p> </p><p>In addition to HIV testing at SHCs and self-sampling funded by local authorities Public Health England (PHE) has contracted HIV Prevention England to undertake a national programme of HIV prevention for high risk populations to promote key HIV prevention messages including HIV testing and safer sexual behaviours. PHE is also working with NHS England to clarify commissioning arrangements for treatment as prevention to accelerate this progress.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/07/2017 09:51:11 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

748202

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Tomography
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that MRI scans can better detect cancer tumours.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	2677
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>Magnetic Resonance Imaging (MRI) scanning is an increasingly important element of cancer diagnosis and assessment for cancer treatment. It allows detailed imaging of tumours and in some cases the detection of possible spread. This is important for accurate diagnosis and effective treatment.</p><p> </p><p>NHS England’s National Cancer Programme has a number of initiatives underway to support the delivery of key strategic priorities including the National Diagnostic Capacity Fund. The fund is an investment in specific projects and interventions to change the way we deliver diagnostic services and unlock capacity by delivering more efficiently. The fund is focusing on redesigning and streamlining patient pathways, to ensure that patients receive the right tests at the right time, including MRI scans, as efficiently as possible.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/07/2017 09:32:17 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

748203

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Parkinson's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges on any connection between Parkinson's disease and faulty immune cells.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	2680
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>No discussions have taken place between Ministers of the Department and the Royal Colleges on this matter.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/07/2017 09:29:33 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

748205

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pregnancy: Paracetamol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges on the potential effect of pregnant women taking paracetamol and its effect on unborn boys.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	2682
answer	answer is ministerial correction date of answer 12/07/2017 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) continuously monitors the safety of all medicines on the market in the United Kingdom and seeks independent expert advice from the Commission on Human Medicines on important new safety issues. The MHRA is aware of recently published research looking at the effect on male offspring of giving paracetamol to pregnant mice. All new evidence on the safety of paracetamol is kept under close review and this latest study will be carefully considered and any new advice will be communicated.</p><p> </p><p>There have not been any discussions with the Royal Colleges on this issue yet.</p><p> </p><p>Pregnant women should speak to their doctor or midwife before taking any medicine, including paracetamol.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/07/2017 09:46:19 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

748207

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Innovative Medicines and Medical Technology Review
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he plans to publish the Government's response to the Accelerated Access Review, published in October 2016.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	2743
answer	answer is ministerial correction date of answer 12/07/2017 answer text <p>We are considering the recommendations carefully and will provide a formal response in due course. Taking forward the Accelerated Access Review remains an important manifesto commitment, ensuring patients can access new cost-effective drugs and treatments faster.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/07/2017 09:15:08 answering member 4067 label Biography information for Steve Brine
tabling member	4465 label Biography information for Ronnie Cowan

748208

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, why expenditure on adult drug misuse services in England has fallen by over £42 million since 2013-14.
tabling member constituency	Inverclyde
tabling member printed	Ronnie Cowan
uin	2963
answer	answer is ministerial correction date of answer 11/07/2017 answer text <p>The Government has committed £16 billion in funding to local councils over the current five year spending review period to tackle public health issues. Any decisions on commission of effective drug and alcohol prevention and treatment services are the responsibility of local authorities based on an assessment of local need.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 2783 question first answered 11/07/2017 09:49:47 answering member 4067 label Biography information for Steve Brine
tabling member	4465 label Biography information for Ronnie Cowan

748209

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to secure an affordable price for Orkambi, to make it available to people with cystic fibrosis.
tabling member constituency	Tooting
tabling member printed	Dr Rosena Allin-Khan
uin	2960
answer	answer is ministerial correction date of answer 12/07/2017 answer text <p>Ministers and Government officials have had a number of discussions with Vertex and NHS England in which the availability of Orkambi for the treatment of cystic fibrosis was raised.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is the independent body that develops guidance for the National Health Service on whether new drugs and treatments represent a clinically and cost effective use of resources.</p><p> </p><p>NICE published final guidance on the use of Orkambi (lumacaftor-ivacaftor) for treating cystic fibrosis homozygous for the F508del mutation in July 2016 that does not recommend this treatment.</p><p> </p><p>Where NICE has not been able to recommend a treatment, funding decisions should be made by the relevant NHS commissioner, based on an assessment of the available evidence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/07/2017 09:12:44 answering member 4067 label Biography information for Steve Brine
tabling member	4573 label Biography information for Dr Rosena Allin-Khan